[144] Rocket Pharmaceuticals, Inc. SEC Filing
Form 144 filing for Rocket Pharmaceuticals, Inc. (RCKT) shows a proposed sale of 1,004 common shares through Fidelity Brokerage Services with an aggregate market value of $3,077.46, planned for 08/18/2025 on NASDAQ. The shares were acquired by the filer on 08/14/2025 through restricted stock vesting as compensation. The filing also discloses two recent sales by the same person in the prior three months: 587 shares sold on 05/20/2025 for $3,783.80 and 12,109 shares sold on 08/14/2025 for $36,553.44. The notice includes the signer鈥檚 representation that they are not aware of undisclosed material adverse information about the issuer.
Deposito del modulo 144 per Rocket Pharmaceuticals, Inc. (RCKT) indica una proposta di vendita di 1.004 azioni ordinarie tramite Fidelity Brokerage Services per un valore di mercato complessivo di $3.077,46, prevista per il 18/08/2025 sul NASDAQ. Le azioni sono state acquisite dal dichiarante il 14/08/2025 tramite l'acquisto derivante dal vesting di azioni ristrette come compenso. Il deposito segnala inoltre due cessioni recenti della stessa persona nei precedenti tre mesi: 587 azioni vendute il 20/05/2025 per $3.783,80 e 12.109 azioni vendute il 14/08/2025 per $36.553,44. L'avviso include la dichiarazione del firmatario di non essere a conoscenza di informazioni materiali avverse non divulgate sull'emittente.
Presentaci贸n del formulario 144 para Rocket Pharmaceuticals, Inc. (RCKT) muestra una propuesta de venta de 1.004 acciones comunes a trav茅s de Fidelity Brokerage Services con un valor de mercado agregado de $3.077,46, prevista para el 18/08/2025 en el NASDAQ. Las acciones fueron adquiridas por el declarante el 14/08/2025 mediante la consolidaci贸n (vesting) de acciones restringidas como compensaci贸n. La presentaci贸n tambi茅n revela dos ventas recientes por la misma persona en los tres meses anteriores: 587 acciones vendidas el 20/05/2025 por $3.783,80 y 12.109 acciones vendidas el 14/08/2025 por $36.553,44. El aviso incluye la declaraci贸n del firmante de que no tiene conocimiento de informaci贸n adversa material no divulgada sobre el emisor.
Rocket Pharmaceuticals, Inc. (RCKT)鞐� 雽�頃� Form 144 鞝滌稖鞚� Fidelity Brokerage Services毳� 韱淀暣 齑� 鞁滉皜臧� $3,077.46鞚� 1,004 氤错喌欤� 毵る弰毳� 2025-08-18鞐� NASDAQ鞐愳劀 瓿勴殟頃橁碃 鞛堨潓鞚� 氤挫棳欷嶋媹雼�. 頃措嫻 欤检嫕鞚� 鞁犼碃鞚胳澊 2025-08-14鞐� 氤挫儊鞙茧靹� 鞝滍暅欤�(毽姢韸鸽Ν韹半摐 鞀ろ啞)鞚� 氩犾姢韺呾溂搿� 旆摑頃� 瓴冹瀰雼堧嫟. 鞝滌稖靹滌棎電� 霕愴暅 霃欖澕鞚胳澊 斓滉芳 3臧滌洈 雮挫棎 頃� 霊� 瓯挫潣 毵る弰 雮挫棴鞚� 瓿店皽霅橃柎 鞛堨姷雼堧嫟: 587欤茧ゼ 2025-05-20鞐� $3,783.80鞐� 毵る弰頄堦碃, 12,109欤茧ゼ 2025-08-14鞐� $36,553.44鞐� 毵る弰頄堨姷雼堧嫟. 韱奠靹滌棎電� 氚滍枆須岇偓鞐� 雽�頃� 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 靹滊獏鞛愱皜 歆勳垹頃橁碃 鞛堨姷雼堧嫟.
D茅p么t du formulaire 144 pour Rocket Pharmaceuticals, Inc. (RCKT) indique une proposition de vente de 1 004 actions ordinaires via Fidelity Brokerage Services pour une valeur de march茅 totale de 3 077,46 $, pr茅vue le 18/08/2025 sur le NASDAQ. Les actions ont 茅t茅 acquises par le d茅posant le 14/08/2025 suite au vesting d'actions restreintes en tant que r茅mun茅ration. Le d茅p么t r茅v猫le 茅galement deux ventes r茅centes par la m锚me personne au cours des trois mois pr茅c茅dents : 587 actions vendues le 20/05/2025 pour 3 783,80 $ et 12 109 actions vendues le 14/08/2025 pour 36 553,44 $. L'avis comprend la d茅claration du signataire qu'il n'a pas connaissance d'informations d茅favorables significatives non divulgu茅es concernant l'茅metteur.
Formular 144-Einreichung 蹿眉谤 Rocket Pharmaceuticals, Inc. (RCKT) weist einen geplanten Verkauf von 1.004 Stammaktien 眉ber Fidelity Brokerage Services mit einem Gesamtmarktwert von $3.077,46 aus, vorgesehen 蹿眉谤 den 18.08.2025 an der NASDAQ. Die Aktien wurden vom Einreicher am 14.08.2025 durch Vesting von eingeschr盲nkten Aktien als Verg眉tung erworben. Die Einreichung offenbart zudem zwei k眉rzliche Verk盲ufe derselben Person in den vorangegangenen drei Monaten: 587 Aktien verkauft am 20.05.2025 蹿眉谤 $3.783,80 und 12.109 Aktien verkauft am 14.08.2025 蹿眉谤 $36.553,44. Die Mitteilung enth盲lt die Erkl盲rung des Unterzeichners, dass ihm keine nicht offengelegten wesentlichen nachteiligen Informationen 眉ber den Emittenten bekannt sind.
- None.
- None.
Insights
TL;DR: Routine insider sale notification; small-dollar proposed sale following restricted stock vesting and prior recent dispositions.
The filing documents a prospectus-exempt sale under Rule 144 of 1,004 common shares valued at $3,077.46 and states the shares were obtained via restricted stock vesting on 08/14/2025 as compensation. The filer previously sold 587 and 12,109 shares in the past three months, generating gross proceeds of $3,783.80 and $36,553.44 respectively. From a compliance viewpoint, the form provides required broker and acquisition details and the signer鈥檚 attestation about material nonpublic information.
TL;DR: Filing is a standard disclosure of insider sales and compensation-related share vesting; procedural compliance appears met.
The document identifies the broker, sale timing, acquisition method (restricted stock vesting), and includes the mandatory representation regarding undisclosed material information. It also lists recent sales by the same person during the three-month lookback. The disclosure content aligns with Rule 144 reporting requirements and provides transparency about insider stock movements.
Deposito del modulo 144 per Rocket Pharmaceuticals, Inc. (RCKT) indica una proposta di vendita di 1.004 azioni ordinarie tramite Fidelity Brokerage Services per un valore di mercato complessivo di $3.077,46, prevista per il 18/08/2025 sul NASDAQ. Le azioni sono state acquisite dal dichiarante il 14/08/2025 tramite l'acquisto derivante dal vesting di azioni ristrette come compenso. Il deposito segnala inoltre due cessioni recenti della stessa persona nei precedenti tre mesi: 587 azioni vendute il 20/05/2025 per $3.783,80 e 12.109 azioni vendute il 14/08/2025 per $36.553,44. L'avviso include la dichiarazione del firmatario di non essere a conoscenza di informazioni materiali avverse non divulgate sull'emittente.
Presentaci贸n del formulario 144 para Rocket Pharmaceuticals, Inc. (RCKT) muestra una propuesta de venta de 1.004 acciones comunes a trav茅s de Fidelity Brokerage Services con un valor de mercado agregado de $3.077,46, prevista para el 18/08/2025 en el NASDAQ. Las acciones fueron adquiridas por el declarante el 14/08/2025 mediante la consolidaci贸n (vesting) de acciones restringidas como compensaci贸n. La presentaci贸n tambi茅n revela dos ventas recientes por la misma persona en los tres meses anteriores: 587 acciones vendidas el 20/05/2025 por $3.783,80 y 12.109 acciones vendidas el 14/08/2025 por $36.553,44. El aviso incluye la declaraci贸n del firmante de que no tiene conocimiento de informaci贸n adversa material no divulgada sobre el emisor.
Rocket Pharmaceuticals, Inc. (RCKT)鞐� 雽�頃� Form 144 鞝滌稖鞚� Fidelity Brokerage Services毳� 韱淀暣 齑� 鞁滉皜臧� $3,077.46鞚� 1,004 氤错喌欤� 毵る弰毳� 2025-08-18鞐� NASDAQ鞐愳劀 瓿勴殟頃橁碃 鞛堨潓鞚� 氤挫棳欷嶋媹雼�. 頃措嫻 欤检嫕鞚� 鞁犼碃鞚胳澊 2025-08-14鞐� 氤挫儊鞙茧靹� 鞝滍暅欤�(毽姢韸鸽Ν韹半摐 鞀ろ啞)鞚� 氩犾姢韺呾溂搿� 旆摑頃� 瓴冹瀰雼堧嫟. 鞝滌稖靹滌棎電� 霕愴暅 霃欖澕鞚胳澊 斓滉芳 3臧滌洈 雮挫棎 頃� 霊� 瓯挫潣 毵る弰 雮挫棴鞚� 瓿店皽霅橃柎 鞛堨姷雼堧嫟: 587欤茧ゼ 2025-05-20鞐� $3,783.80鞐� 毵る弰頄堦碃, 12,109欤茧ゼ 2025-08-14鞐� $36,553.44鞐� 毵る弰頄堨姷雼堧嫟. 韱奠靹滌棎電� 氚滍枆須岇偓鞐� 雽�頃� 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 靹滊獏鞛愱皜 歆勳垹頃橁碃 鞛堨姷雼堧嫟.
D茅p么t du formulaire 144 pour Rocket Pharmaceuticals, Inc. (RCKT) indique une proposition de vente de 1 004 actions ordinaires via Fidelity Brokerage Services pour une valeur de march茅 totale de 3 077,46 $, pr茅vue le 18/08/2025 sur le NASDAQ. Les actions ont 茅t茅 acquises par le d茅posant le 14/08/2025 suite au vesting d'actions restreintes en tant que r茅mun茅ration. Le d茅p么t r茅v猫le 茅galement deux ventes r茅centes par la m锚me personne au cours des trois mois pr茅c茅dents : 587 actions vendues le 20/05/2025 pour 3 783,80 $ et 12 109 actions vendues le 14/08/2025 pour 36 553,44 $. L'avis comprend la d茅claration du signataire qu'il n'a pas connaissance d'informations d茅favorables significatives non divulgu茅es concernant l'茅metteur.
Formular 144-Einreichung 蹿眉谤 Rocket Pharmaceuticals, Inc. (RCKT) weist einen geplanten Verkauf von 1.004 Stammaktien 眉ber Fidelity Brokerage Services mit einem Gesamtmarktwert von $3.077,46 aus, vorgesehen 蹿眉谤 den 18.08.2025 an der NASDAQ. Die Aktien wurden vom Einreicher am 14.08.2025 durch Vesting von eingeschr盲nkten Aktien als Verg眉tung erworben. Die Einreichung offenbart zudem zwei k眉rzliche Verk盲ufe derselben Person in den vorangegangenen drei Monaten: 587 Aktien verkauft am 20.05.2025 蹿眉谤 $3.783,80 und 12.109 Aktien verkauft am 14.08.2025 蹿眉谤 $36.553,44. Die Mitteilung enth盲lt die Erkl盲rung des Unterzeichners, dass ihm keine nicht offengelegten wesentlichen nachteiligen Informationen 眉ber den Emittenten bekannt sind.
